Rocket


News + Filings
Transactions





Keson-Brookes Maiken

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
02/01/2022Rubius Therapeutics, Inc.RUBYSaleCommon Stock2.7k$6.57$18k 01/29/2022
01/31/2022Rubius Therapeutics, Inc.RUBYGrantStock Option (Right to Buy)143.8k$6.75$970.3k 01/29/2022
01/31/2022Rubius Therapeutics, Inc.RUBYGrantRestricted Stock Units34.5k$0.00$0 01/29/2022
01/29/2022Rubius Therapeutics, Inc.RUBYExerciseRestricted Stock Units8.1k$0.00$0 01/29/2022
03/15/2021Rubius Therapeutics, Inc.RUBYSaleCommon Stock25k$20.24$506k 03/15/2021
03/15/2021Rubius Therapeutics, Inc.RUBYExerciseStock Option (Right to Buy)25k$7.70$192.5k 03/15/2021
01/29/2021Rubius Therapeutics, Inc.RUBYGrantRestricted Stock Units32.3k$0.00$0 01/29/2021
01/29/2021Rubius Therapeutics, Inc.RUBYGrantStock Option (Right to Buy)142.5k$11.97$1.7M 01/29/2021
11/29/2019Rubius Therapeutics, Inc.RUBYGrantStock Option (Right to Buy)250k$7.70$1.9M 11/29/2019
01/27/2017uniQure N.V.QUREGrantStock Option (Right to Buy)43.2k$5.37$232.3k 01/27/2017
01/27/2017uniQure N.V.QUREGrantPerformance Share Unit43.2k$0.00$0 01/27/2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy